SCHEMBL6133513

SCHEMBL6133513

CCCNC(=O)c1nc(-c2ccccc2)c(-c2ccc(=O)n(C)n2)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
MAPT P10636 2/20 0.46
HTT P42858 1/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
HPGD P15428 3/20 0.43
KDM4E B2RXH2 2/20 0.43
GAA P10253 2/20 0.43
POLB P06746 2/20 0.42
HSD17B10 Q99714 2/20 0.42
DGAT1 O75907 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
TP53 P04637 2/20 0.39
ADORA2A P29274 1/20 0.38
USP2 O75604 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
BRD4 O60885 1/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6133443 0.90 HSD17B10 (0.50) ALDH1A1MAPTHTTMEN1KMT2A
SCHEMBL6133574 0.89 HSD17B10 (0.46) ALDH1A1HTTMEN1KMT2AHPGD
SCHEMBL6134311 0.87 HPGD (0.41) ALDH1A1MAPTHTTMEN1KMT2A
SCHEMBL6133557 0.86 MEN1 (0.48) ALDH1A1MEN1KMT2AHPGDKDM4E
SCHEMBL6133509 0.84 TSHR (0.48) ALDH1A1MAPTHTTMEN1KMT2A
SCHEMBL6133434 0.83 ALDH1A1 (0.46) ALDH1A1MAPTHTTMEN1KMT2A
SCHEMBL6133470 0.83 ALDH1A1 (0.47) ALDH1A1MAPTHTTKDM4EHSD17B10
SCHEMBL6133994 0.82 ALDH1A1 (0.46) ALDH1A1MAPTHTTKDM4EPOLB
SCHEMBL6134322 0.82 PTGS2 (0.46) ALDH1A1MAPTHTTMEN1KMT2A
SCHEMBL6133793 0.81 HSD17B10 (0.46) HTTMEN1KMT2AKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2005-01-06 US disclosed
EP-1441732-A2 THIAZOLE DERIVATIVE AND PHARMACEUTICAL USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-04 EP disclosed
WO-2003039451-A2 THIAZOLE PYRIDAZINONES AS ADENOSINE ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof MC2R, CYP2C9, OXTR ALDH1A1 630/4885MAPT 3008/4885HTT 477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.